Back

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

27 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Drugs and devices in hypertension Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Anna Moiseeva

Institute of Cardiology, Chisinau (Moldova (Republic of))

7 More presentations in this session

Presentation thumbnail
The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials
Doctor M. Ibrahim (Flint, US)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension
Professor J. Wang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis
Professor N. Ntusi (Rondebosch, ZA)
Abstract Slides Video
Presentation thumbnail
Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension
Associate Professor G. Abdullaeva (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials
Doctor E. Manta (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Drugs and devices in hypertension

The Event

Event poster

ESC Congress 2023

27 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
10 years after treatment with renal denervation of the sympathetic nerves for resistant hypertension: what happened to the patients and their office blood pressure? An observational study
thumbnail
Congress Presentation
The impact of modulation of SNS activity on the evolution of heart failure and exercise capacity in patients with resistant hypertension and heart failure with preserved ejection fraction
thumbnail
Congress Presentation
When to use renal denervation in hypertension management

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources